SiPhox Health

📍 Burlington, United States👥 72 employees💰 Last funded Feb 2026
At SiPhox Health, our mission is to tackle the problem of chronic diseases by enabling new Direct-to-Consumer health and wellness solutions. With six out of ten Americans living with chronic conditions, we’re dedicated to revolutionizing health diagnostics with next-generation infrastructure for home use. SiPhox was founded by MIT scientists Michael Dubrovsky and Diedrik Vermeulen to integrate microfluidics and biochemistry with Silicon Photonics to miniaturize protein and hormone testing. As we work on building advanced home diagnostic devices, we are creating the most comprehensive at-home test kit on the market, providing valuable health insights and actionable plans to help achieve health goals. The entire SiPhox team is driven by a shared passion: combating the chronic disease epidemic. We envision a future where staying healthy is not only affordable and convenient but also enjoyable for everyone. This mission is deeply personal to us – its about our own well-being, the health of our families, and the prosperity of humanity as a whole.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography3 countries
United States
1
United Kingdom
1
Israel
1
Investor activity2023–2026 · investors recorded per year
202312025120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in SiPhox Health?
SiPhox Health has 3 investors on record on gritt.io.
When did SiPhox Health last raise funding?
The most recent investment in SiPhox Health recorded on gritt.io was in February 2026.
What industry is SiPhox Health in?
SiPhox Health operates in Consumer Services. Find similar Consumer Services investors on gritt.io.
Where is SiPhox Health based?
SiPhox Health is headquartered in Burlington, United States.